Achieve Life Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Achieve Life Sciences, Inc. (ACHV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $1.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2021-03-11
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $1.00M, a 11.11% increase from fiscal 2019.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2019 was $900.00K, a 10.00% decline from fiscal 2018.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $1.00M, a 166666566.67% increase from fiscal 2017.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $0.60.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|
| 2020-12-31 | $1.00M 10-K · filed 2021-03-11 | |
| 2019-12-31 | $900.00K 10-K · filed 2021-03-11 | |
| 2018-12-31 | $1.00M 10-K · filed 2021-03-11 | |
| 2017-12-31 | $0.60 10-K · filed 2020-03-13 | $600.00K 10-K · filed 2018-03-01 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-14 | $1.00M 10-K · filed 2017-02-23 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 | $1.30M 10-K · filed 2016-03-09 |
| 2014-12-31 | $1.90M 10-K · filed 2017-02-23 | |
| 2013-12-31 | $1.80M 10-K · filed 2016-03-09 | |
| 2012-12-31 | $1.60M 10-K · filed 2015-03-26 | |
| 2011-12-31 | $1.10M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |